Opportunity ID: 351684

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-24-105
Funding Opportunity Title: Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.351 — Research Infrastructure Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 03, 2024
Last Updated Date: Jan 03, 2024
Original Closing Date for Applications: Sep 01, 2024
Current Closing Date for Applications: Sep 01, 2024
Archive Date: Oct 07, 2024
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

See full Notice of Funding Opportunity for additional details on eligibility.

Additional Information

Agency Name: National Institutes of Health
Description: This Notice of Funding Opportunity (NOFO) invites applications for the continued support and advancement of the Mutant Mouse Resource and Research Centers (MMRRC). The MMRRC consortium is expected to facilitate research by identifying, acquiring, evaluating, characterizing, cryopreserving, and distributing mutant mouse strains to qualified biomedical investigators. A regional network of four MMRRCs and an Informatics, Coordination and Service Center (ICSC) collectively serve the needs of the biomedical research community for transgenic, knockout and other genetically-engineered mutant mice and related biomaterials. MMRRC strains are held to the highest standards to optimize reproducibility of studies and assure scientific rigor and transparency; all submitted strains are thoroughly reviewed and documented and include additional quality control measures. The Program Director/Principal Investigator (PD/PI) of each MMRRC in addition to the major resource activities is required to develop a small high risk, high return, research pilot project that complements the goals and needs of the MMRRC consortium.
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-24-105.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 351684 Full Announcement-PAR-24-105 -> PAR-24-105-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00284326 Apr 01, 2024 Sep 01, 2024 View

Package 1

Mandatory forms

351684 RR_SF424_5_0-5.0.pdf

351684 PHS398_CoverPageSupplement_5_0-5.0.pdf

351684 RR_OtherProjectInfo_1_4-1.4.pdf

351684 PerformanceSite_4_0-4.0.pdf

351684 RR_KeyPersonExpanded_4_0-4.0.pdf

351684 PHS398_ResearchPlan_5_0-5.0.pdf

351684 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

351684 PHS_Additional_IndirectCosts_2_0-2.0.pdf

351684 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T02:16:20-05:00

Share This Post, Choose Your Platform!

About the Author: